XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Segment Information (Tables) | 6 Months Ended
--- | ---
Dec. 31, 2024
Notes Tables |
Schedule of financial information by reportable segment | The following is financial information relating to the Company's reportable segments (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Quarter Ended | ​ | Six Months Ended
​ | ​ | December 31, | ​ | December 31,
​ |  | 2024 |  | 2023 | ​ | 2024 |  | 2023
Net sales: |  | ​ |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​
Protein Sciences | ​ | $ | 211,551 |  | $ | 197,670 | ​ | $ | 416,086 |  | $ | 402,325
Diagnostics and Spatial Biology | ​ |  | 84,135 | ​ |  | 75,408 | ​ |  | 167,327 | ​ |  | 148,204
Other revenue(1) | ​ | ​ | 1,849 | ​ | ​ | — | ​ | ​ | 4,152 | ​ | ​ | —
Intersegment | ​ |  | (504) | ​ |  | (480) | ​ |  | (1,076) | ​ |  | (996)
Consolidated net sales | ​ | $ | 297,031 |  | $ | 272,598 | ​ | $ | 586,489 |  | $ | 549,533
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating income: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Protein Sciences | ​ | $ | 87,112 |  | $ | 79,586 | ​ | $ | 167,653 |  | $ | 167,947
Diagnostics and Spatial Biology | ​ |  | 3,240 | ​ |  | 4,556 | ​ |  | 7,517 | ​ |  | 5,082
Segment operating income | ​ | $ | 90,352 | ​ | $ | 84,142 | ​ | $ | 175,170 | ​ | $ | 173,029
Costs recognized on sale of acquired inventory | ​ |  | (185) | ​ |  | (183) | ​ |  | (373) | ​ |  | (364)
Amortization of intangibles | ​ |  | (18,559) | ​ |  | (19,769) | ​ |  | (38,300) | ​ |  | (39,620)
Acquisition related expenses and other | ​ |  | (2,010) | ​ |  | 525 | ​ |  | (3,523) | ​ |  | 1,114
Certain litigation charges | ​ | ​ | (1,386) | ​ | ​ | — | ​ | ​ | (1,678) | ​ | ​ | —
Impairment of assets held-for-sale | ​ | ​ | — | ​ | ​ | (6,038) | ​ | ​ | — | ​ | ​ | (6,038)
Stock based compensation, inclusive of employer taxes | ​ |  | (15,238) | ​ |  | (12,958) | ​ |  | (25,875) | ​ |  | (24,453)
Restructuring and restructuring-related costs | ​ |  | (3,287) | ​ |  | (5,518) | ​ |  | (14,309) | ​ |  | (5,607)
Corporate general, selling, and administrative expenses | ​ |  | (1,641) | ​ |  | (2,197) | ​ |  | (3,227) | ​ |  | (4,195)
Impact of business held-for-sale(1) | ​ | ​ | (627) | ​ | ​ | — | ​ | ​ | (479) | ​ | ​ | —
Consolidated operating income | ​ | $ | 47,419 |  | $ | 38,004 | ​ | $ | 87,406 |  | $ | 93,866
(1) Includes the quarterly results of a business that has met the held-for-sale criteria since December 31, 2023.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration